High mobility group box 1 pseudogene 26 (HMGB1P26)

HMGB1P26 is a human pseudogene related to the functional high mobility group box 1 (HMGB1) gene[1][2][4][6][8]. Pseudogenes are genomic DNA sequences similar to functional genes but are considered nonfunctional due to disabling mutations, lack of transcriptional control elements, or inability to produce functional protein product[5][9]. HMGB1P26 is annotated as a processed pseudogene, meaning it likely originated from an mRNA transcript that was reverse-transcribed and inserted into the genome at a new location[8][9][5]. There is currently no evidence for a direct biological function, disease association, or therapeutic potential of HMGB1P26 specifically; however, some pseudogenes may play indirect regulatory roles, such as acting as competitive endogenous RNAs or miRNA decoys in gene expression networks[3][5][9]. HMGB1P26 does not code for a protein and is not a recognized drug target, biomarker, or receptor. Summary: HMGB1P26 is a pseudogene, not a protein-coding gene, receptor, enzyme, or recognized therapeutic target. Its main relevance is genomic annotation and potential research in noncoding RNA regulatory mechanisms, not direct clinical or pharmacological applications[1][2][3][4][5][6][8][9].

Other names

High-mobility group box 1 pseudogene 26

None for drugs, as this is not a protein, receptor, or enzyme target. Hypothetical regulatory mechanisms (e.g., miRNA sponge) may broadly apply to some pseudogenes.